Liposomes, the most widely studied nano-drug carriers in drug delivery, are sphere-shaped
vesicles consisting of one or more phospholipid bilayers. Compared with traditional drug …

Over the past decades, lipid‐based nanoparticle drug delivery systems (DDS) have caught
the attention of researchers worldwide, encouraging the field to rapidly develop improved …

Cancer is difficult to cure due to frequent metastasis, and developing effective therapeutic
approaches to treat cancer is urgently important. Long non-coding RNAs (lncRNAs) have …

Nanomedicine is an emerging form of therapy that focuses on alternative drug delivery and
improvement of the treatment efficacy while reducing detrimental side effects to normal …

Nanomedicine, particularly liposomal drug delivery, has expanded considerably over the
past few decades, and several liposomal drugs are already providing improved clinical …

In recent years, various nanotechnology platforms in the area of medical biology, including
both diagnostics and therapy, have gained remarkable attention. Moreover, research and …

Liposomes, phospholipid vesicles with a bilayered membrane structure, have been widely
used as pharmaceutical carriers for drugs and genes, in particular for treatment of cancer. To …

Over the past three decades, taxanes represent one of the most important new classes of
drugs approved in oncology. Paclitaxel (PTX), the prototype of this class, is an anti-cancer …

One of the main goals of nanomedicine is to develop a nanocarrier that can selectively
deliver anticancer drugs to the targeted tumors. Extensive efforts have resulted in several …

In the last few years, nanostructures have gained considerable interest for the safe delivery
of therapeutic agents. Several therapeutic approaches have been reported, such as …